Boyd Peter E.

CIK 00017398161 companyWARREN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001739816

Recent Transactions

29 trades

Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-10$4.17/sh−29,814→ 338,509 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2026-03-09$4.29/sh+42,500→ 42,500 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2026-03-09+80,000→ 368,323 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-12-04+20,000→ 288,323 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-10-15$7.00/sh−10,000→ 268,323 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-26$6.30/sh−10,000→ 278,323 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-09-05$5.30/sh−15,000→ 288,323 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-09$2.65/sh−7,681→ 303,323 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07$2.65/sh−6,624→ 311,004 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2025-03-07+80,000→ 317,628 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2025-03-07+40,000→ 40,000 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−8,370→ 237,628 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-07+86,250→ 245,998 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2024-03-07+43,125→ 43,125 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-08-09+50,000→ 50,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-05-05+50,000→ 50,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2023-03-09+100,000→ 159,532 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-11-04+25,000→ 25,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2022-06-14$0.81/sh+5,000→ 59,532 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2022-06-08$0.96/sh+2,293→ 54,532 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Warrant (Right to Buy)
2022-06-08$0.13/sh+2,293→ 2,293 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-03-10+70,000→ 70,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2021-03-11+35,000→ 35,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2020-03-16+50,700→ 50,700 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-03-16$1.50/sh+2,000→ 52,239 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-12$3.81/sh+600→ 50,239 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2019-02-28+30,000→ 30,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2018-11-21$9.98/sh+200→ 49,639 total
Award
Aquestive Therapeutics, Inc.$AQST
Stock Option (Right to Purchase)
2018-07-24+36,223→ 36,223 total

Companies

Aquestive Therapeutics, Inc.
Chief People Officer
$AQST

Recent Filings

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059

View on SEC.gov